[EN] TRIAZINES SUITABLE FOR USE IN FABRIC TREATMENT COMPOSITIONS<br/>[FR] TRIAZINES POUVANT ETRE UTILISEES DANS DES COMPOSITIONS DE TRAITEMENT DE TISSUS
申请人:UNILEVER PLC
公开号:WO2005123699A1
公开(公告)日:2005-12-29
A water-soluble, triazine-based, non-dye, cellulose cross-linking agent that has a highly flexible linking group between at least two, mono-reactive cross-linking moieties and further hydrophilic or non-hydrophilic substituents, being preferrably represented by the general formula (I): (R1)(X1)T-L1-B-T(X2)(R2) wherein: R1 et R2 are cellulose-unreactive substituent groups on the s-triazine (T) and may be the same or different, X1 and X2 are leaving groups on the s-triazine which are lost on reaction with cellulose and may be the same or different, L1 et L2 are linking groups, an may be the same or different or absent, B is the bridging group comprising or consisting of at least one aliphatic polyoalkylene chain.
[EN] COMPOSITIONS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS<br/>[FR] COMPOSÉS ET MÉTHODES POUR LE TRAITEMENT D'INFECTIONS BACTÉRIENNES
申请人:CIDARA THERAPEUTICS INC
公开号:WO2018006063A1
公开(公告)日:2018-01-04
Compositions and methods for the treatment of bacterial infections include compounds containing dimers of cyclic heptapeptides conjugated to one or more monosaccharide or oligosaccharide moieties. In particular, compounds can be used in the treatment of bacterial infections caused by Gram-negative bacteria.
[EN] PEPTIDE-BASED MULTIPLE-DRUG DELIVERY VEHICLE<br/>[FR] VÉHICULE D'ADMINISTRATION DE MÉDICAMENTS MULTIPLES À BASE DE PEPTIDES
申请人:ARIEL-UNIVERSITY RES AND DEV COMPANY LTD
公开号:WO2017068577A1
公开(公告)日:2017-04-27
A molecular structure comprising a targeting moiety, a multi-functional peptide platform and a plurality of controllably released bioactive agents attached thereto is provided herein.
本文提供了一种包括靶向基团、多功能肽平台和附着在其上的多种可控释放的生物活性剂的分子结构。
Method and compositions for identifying anti-HIV therapeutic compounds
申请人:GILEAD SCIENCES, INC.
公开号:US20040121316A1
公开(公告)日:2004-06-24
Methods are provided for identifying anti-HIV therapeutic compounds substituted with carboxyl ester or phosphonate ester groups. Libraries of such compounds are screened optionally using the novel enzyme GS-7340 Ester Hydrolase. Compositions and methods relating to GS-7340 Ester Hydrolase also are provided.
申请人:Max-Delbrück-Centrum für Molekulare Medizin (MDC)
公开号:EP2208720A1
公开(公告)日:2010-07-21
The present invention provides compounds (n-3 PUFA derivatives) of formula (I):
that modulate conditions associated with cardiac damage, especially cardiac arrhythmias.